jain.com

p2kLabs acquisition

Company: CleanSpark

This claim was marked delayed on September 15, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
acquisition
Statement date
2020-05-10
Promised by
2020-01-31
Promised amount
1688935.0 USD
Current status
delayed

The claim, verbatim

Company purchased all issued and outstanding shares of p2kLabs, Inc. for aggregate consideration of $1,688,935 in cash and equity.

Source (primary)

CleanSpark 10-Q filed 2020-05-11 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “the Company purchased all of the issued and outstanding shares of p2k from the Seller (the "Transaction") in exchange for an aggregate purchase price of cash and equity of $1,688,935. The Transaction closed simultaneously upon the execution of the Agreement by the parties on January 31, 2020.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms CleanSpark 10-Q filed 2020-05-11

Quote: “the Company purchased all of the issued and outstanding shares of p2k from the Seller (the "Transaction") in exchange for an aggregate purchase price of cash and equity of $1,688,935. The Transaction closed simultaneously upon the execution of the Agreement by the parties on January 31, 2020.”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 14, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 15, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.